| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
JP Morgan analyst Christopher Horvers maintains Target (NYSE:TGT) with a Neutral and lowers the price target from $117 to $100.
Andreessen Horowitz has reportedly paused its five-year-old Talent x Opportunity (TxO) fund supporting underrepresented founder...
Roark eyes a $2B deal for Nothing Bundt Cakes; Forge Global explores a buyer; Dr. Phil's media firm faces liquidation.
Companies are finding that repetitive administrative tasks can be done by AI—and the job cuts are piling up.